Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Harry E. Carmitchel currently holds 70,000 shares of OSIRIS THERAPEUTICS, INC. (OSIR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harry E. Carmitchel has been a net seller of OSIR stock. They have purchased $0 and sold $238.0K worth of shares.
Harry E. Carmitchel's most recent insider trade was on Dec 8, 2008, when they sold 7,000 shares at $19.46 per share.
Harry E. Carmitchel serves as Executive at OSIRIS THERAPEUTICS, INC. (OSIR). They have executed 19 insider transactions totaling $238.0K over their tenure at the company.
Harry E. Carmitchel holds the position of Executive at OSIRIS THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Harry E. Carmitchel has shown a selling trading pattern, with $0 in total purchases and $238.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Harry E. Carmitchel was on Sep 11, 2006, when they sold $140.4K worth of OSIR shares. This transaction involved 13,000 shares at $10.80 per share.
Harry E. Carmitchel currently owns 70,000 shares of OSIRIS THERAPEUTICS, INC. (OSIR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Harry E. Carmitchel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Harry E. Carmitchel has 19 Form 4 filings on record as an insider at OSIRIS THERAPEUTICS, INC..
Set alerts for Harry E. Carmitchel and 40,000+ other insiders.